[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Black Swan Analysis limited: Market Research Reports

Black Swan Analysis is a provider of insightful commercialization ideas for the clients engaged in the healthcare sector.

The company delivers one-of-a-kind solutions, reliable epidemiology data, market and product overviews, and business opportunity evaluation for the clients who want to increase their capacity in producing and selling healthcare products.

Black Swan Analysis is an unrestricted resource of avant-garde solutions to the clients who want to upgrade their performance at the healthcare market. Our experience and ability to penetrate to the core of the problem enable us to produce exclusive market research reports that contain a variety of useful information including:

  • Product profile
  • SWOT analysis
  • Growth drivers
  • Market share
  • Supply and demand channels
  • Analysis of Competitors’ products and services
  • New application areas

To ensure precise forecasting, we explore and analyze a vast variety of epidemiological and pathological data and study disease environment. Our clients can access disease epidemiology information and receive the accurate evaluation of the pricing policies of proprietors in the healthcare and pharmaceutical business.

We do not let our customers leave our company with half-baked information and weak decisions. Clients with unmet expectations are not about us. They appreciate Black Swan Analysis for adaptable solutions, proficiency, cost-effectiveness, and unique methodologies.

We help our pharmaceutical and healthcare partners recharge their capacities and increase their competitive rates. Our service algorithm is to work in close cooperation with the customer. Consistent inclusive communication helps us approach every commercial challenge expertly and invent unique business solutions.

Publications found: 186
Sort by:

Epiomic Epidemiology Series: Idiopathic Pulmonary Fibrosis Forecast in 9 Major Markets 2015-2025

US$ 6,382.00

Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic, progressive, fibrosing interstitial pneumonia of unknown cause. The disease is idiopathic ... sourced from the proprietary Epiomic patient segmentation database. To ... patient registries, clinical trials and epidemiology studies. All of the ...

November 2015 38 pages

Epiomic Epidemiology Series: Frontotemporal Lobe Dementia Forecast in 9 Major Markets 2015-2025

US$ 6,382.00

Frontotemporal lobe dementia (FTD) is a progressive degenerative disorder characterised by degeneration and atrophy of the frontal and anterior temporal lobes ... sourced from the proprietary Epiomic patient segmentation database. To ... patient registries, clinical trials and epidemiology studies. All of the sources ...

November 2015 38 pages

Epiomic Epidemiology Series: Thyroid Cancer Forecast in 17 Major Markets 2015-2025

US$ 6,382.00

... from the proprietary Epiomic patient segmentation database. To ... registries, clinical trials and epidemiology studies. All of the ... Thyroid Cancer’s incident population. Examination of the incidence of the different causative gene mutations for Thyroid Cancer. Identify sub-populations within Thyroid Cancer ...

November 2015 66 pages

Epiomic Epidemiology Series: Testicular Cancer Forecast in 20 Major Markets 2015-2025

US$ 6,382.00

... from the proprietary Epiomic patient segmentation database. To ... patient registries, clinical trials and epidemiology studies. All of the ... Testicular Cancer’s incident population. Examination of various elevated serum levels present in Testicular Cancer patients. Identify sub-populations within Testicular Cancer ...

November 2015 54 pages

Epiomic Epidemiology Series: Aortic Stenosis Forecast in 16 Major Markets 2015-2025

US$ 6,382.00

Aortic Stenosis (AS) is the occlusion or loss of aortic valve surface area resulting in stenosis of the aortic valve. Currently, AS ... information sourced from the proprietary Epiomic patient segmentation database. To generate ... form patient registries, clinical trials and epidemiology studies. All of the sources ...

November 2015 66 pages

Epiomic Epidemiology Series: Atopic Dermatitis Forecast in 17 Major Markets 2015-2025

US$ 6,382.00

... sourced from the proprietary Epiomic patient segmentation database. To generate ... form patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Atopic Dermatitis’s prevalent population. Identify sub-populations within Atopic Dermatitis which require treatment ...

November 2015 70 pages

Epiomic Epidemiology Series: Cerebral Palsy Forecast in 8 Major Markets 2015-2025

US$ 6,382.00

... information sourced from the proprietary Epiomic patient segmentation database. To generate ... form patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Cerebral Palsy’s prevalent population. Identify sub-populations within Cerebral Palsy which require treatment ...

November 2015 48 pages

Dry Eye Syndrome Epiomic Insights, 2015-2020

US$ 1,055.00

Epiomic Insights for Dry Eye Syndrome provides you with a top line snapshot of the market potential in ... total dry eye syndrome population across all markets has also been segmented by gender type and sub-population types within the syndrome. This ...

November 2015 1 pages

Fabry Disease Epiomic Insights, 2015-2020

US$ 1,055.00

Epiomic Insights for Fabry Disease provides you with a top line snapshot of the market potential for this inherited rare disease. Consisting of a wide variety of symptoms, Fabry disease remains difficult for clinicians to diagnose until symptoms present more severely in adulthood. This disease can ...

November 2015 1 pages

Atrial Fibrillation Epiomic Insights, 2015-2020

US$ 1,055.00

Epiomic Insights for Atrial Fibrillation (AF) provides you with a top line snapshot of the market potential ... will be essential to achieve commercial success. Sourcing data from our Epiomic Patient segmentation database, we are able to reference relevant clinical trial ...

November 2015 1 pages

Gallbladder Cancer Epiomic Insights, 2015-2020

US$ 1,055.00

Epiomic Insights for Gallbladder Cancer (GBC) provides you with a top line snapshot of the market ... patient populations suffering from this rare, and difficult to treat cancer. The ability to diagnose GBC early is seen as a challenge to clinicians and ...

November 2015 1 pages

Huntington's Disease Epiomic Insights, 2015-2020

US$ 1,055.00

Epiomic Insights for Huntington’s disease (HD) provides you with a top line snapshot of the market potential ... style of report is ideal for companies entering a new market segment or disease area of which they have limited knowledge. Alternatively, companies considering ...

November 2015 1 pages

Idiopathic Pulmonary Fibrosis Epiomic Insights, 2015-2020

US$ 1,055.00

Epiomic Insights for Idiopathic Pulmonary Fibrosis delivers a top line snapshot of the market potential for this ... of patients, is essential for commercial success. Sourcing data from our Epiomic Patient segmentation database, we are able to reference relevant clinical trial ...

November 2015 1 pages

Endometriosis Epiomic Insights, 2015-2020

US$ 1,055.00

Epiomic Insights for Endometriosis provides you with a top line snapshot of the market potential ... in obtaining the true prevalent patient population for Endometriosis. Sourcing data from our Epiomic Patient segmentation database, we are able to reference relevant ...

November 2015 1 pages

Gout Epiomic Insights, 2015-2020

US$ 1,055.00

Epiomic Insights for Gout provides you with a top line snapshot of the market potential in ... to quantify potential Gout patients exhibiting severe symptoms in need of more specific or powerful innovative treatments. Sourcing data from our Epiomic Patient segmentation ...

November 2015 1 pages

Fabry Disease Epiomic Insights, 2015-2021

US$ 1,055.00

Epiomic Insights for Fabry Disease provides you with a top line snapshot of the market potential for this inherited rare disease. Consisting of a wide variety of symptoms, Fabry disease remains difficult for clinicians to diagnose until symptoms present more severely in adulthood. This disease can ...

November 2015 1 pages

Epiomic Epidemiology Series: Varicose Veins Forecast in 15 Major Markets 2015-2025

US$ 6,382.00

... varicose veins: trunk, reticular and telangiectasia. This indication report details the prevalence of trunk varicose veins. Trunk varicose veins ... sourced from the proprietary Epiomic patient segmentation database. To generate ... form patient registries, clinical trials and epidemiology studies. All of the sources ...

October 2015 60 pages

Epiomic Epidemiology Series: Atrial Fibrillation Forecast in 18 Major Markets 2015-2025

US$ 6,382.00

Atrial Fibrillation (AF) is the most prevalent type of supraventricular ... data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient ... date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

October 2015 72 pages

Epiomic Epidemiology Series: Tuberculosis Forecast in 11 Major Markets 2015-2025

US$ 6,382.00

Tuberculosis (TB) is a chronic bacterial infection caused by variants of Mycobacterium tuberculosis ... country level across the 10-year forecast snapshot. Main symptoms and ... from the proprietary Epiomic patient segmentation database. To ... patient registries, clinical trials and epidemiology studies. All of the ...

October 2015 52 pages

Epiomic Epidemiology Series: Fabry Disease Forecast in 8 Major Markets 2015-2025

US$ 6,382.00

... information sourced from the proprietary Epiomic patient segmentation database. To generate ... form patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Fabry disease’s prevalent population. Identify sub-populations within Fabry Disease which require treatment. ...

October 2015 42 pages

Epiomic Epidemiology Series: Ovarian Cancer Forecast in 17 Major Markets 2015-2025

US$ 6,382.00

... information sourced from the proprietary Epiomic patient segmentation database. To generate ... form patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Ovarian Cancer’s prevalent population. Identify sub-populations within Ovarian Cancer which require treatment ...

September 2015 50 pages

Epiomic Epidemiology Series: Angina Pectoris Forecast in 8 Major Markets 2015-2025

US$ 6,382.00

... sourced from the proprietary Epiomic patient segmentation database. To generate ... form patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Angina Pectoris’s prevalent population. Identify sub-populations within Angina Pectoris which require treatment ...

September 2015 50 pages

Epiomic Epidemiology Series: Dry Eye Syndrome Forecast in 7 Major Markets 2015-2025

US$ 6,382.00

... Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database ... form patient registries, clinical trials and epidemiology studies. All of the sources used ... conditions on Dry Eye Syndrome’s prevalent population. Identify sub-populations within Dry Eye Syndrome which ...

September 2015 36 pages

Epiomic Epidemiology Series: Gout Forecast in 15 Major Markets 2015-2025

US$ 6,382.00

... level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Gout include: Obesity ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information form patient registries, clinical trials and epidemiology studies. All of the sources used ...

September 2015 74 pages

Epiomic Epidemiology Series: Endometriosis Forecast in 10 Major Markets 2015-2025

US$ 6,382.00

... level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Endometriosis include: ... Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database ... form patient registries, clinical trials and epidemiology studies. All of the sources used ...

September 2015 36 pages

Epiomic Epidemiology Series: Gallbladder Cancer Forecast in 18 Major Markets 2015-2025

US$ 6,382.00

Gallbladder Cancer (GBC) primarily occurs in the gallbladder itself, but also includes ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient ... date information form patient registries, clinical trials and epidemiology studies. All of the sources used to ...

September 2015 62 pages

Epiomic Epidemiology Series: Huntington's Disease Forecast in 8 Major Markets 2015-2025

US$ 6,382.00

... sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources ... conditions on the Huntington’s disease prevalent population. Identify sub-populations within Huntington’s disease which require treatment ...

August 2015 36 pages

Epiomic Epidemiology Series: Uveitis Forecast in 10 Major Markets 2015-2025

US$ 6,382.00

... level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Uveitis include: Autoimmune ... information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... form patient registries, clinical trials and epidemiology studies. All of the sources used ...

August 2015 46 pages

Epiomic Epidemiology Series: Onychomycosis Forecast in 10 Major Markets 2015-2025

US$ 6,382.00

... level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Onychomycosis include: ... information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information form patient registries, clinical trials and epidemiology studies. All of the sources used ...

August 2015 44 pages

Epiomic Epidemiology Series: Wegener's Granulomatosis Forecast in 9 Major Markets 2015-2025

US$ 6,382.00

Wegener’s Granulomatosis (WG), also known as granulomatous with polyangiitis, ... data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient ... date information form patient registries, clinical trials and epidemiology studies. All of the sources used to ...

August 2015 42 pages

Epiomic Epidemiology Series: Retinal Vein Occlusion Forecast in 8 Major Markets 2015-2025

US$ 6,382.00

Retinal Vein Occlusion (RVO) is a common vascular disorder of ... data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient ... date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

August 2015 40 pages

Epiomic Epidemiology Series: Hypertrophic Cardiomyopathy Forecast in 8 Major Markets 2015-2025

US$ 6,382.00

Hypertrophic cardiomyopathy (HCM) is a disease that contains an autosomal ... data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient ... date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

August 2015 38 pages

Epiomic Epidemiology Series: Pulmonary Hypertension Forecast in 8 Major Markets 2015-2025

US$ 6,382.00

Pulmonary Hypertension (PH) is a condition in which pulmonary arterial pressure is 25 mmHg or greater, ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information form patient registries, clinical trials and epidemiology studies. All of the sources used ...

August 2015 50 pages

Epiomic Epidemiology Series: Cystic Fibrosis Forecast in 9 Major Markets 2015-2025

US$ 6,382.00

... Osteoporosis Cirrhosis Cystic Fibrosis Related Diabetes Infertility This report is built using data and information sourced from the proprietary Epiomic patient ... most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data ...

August 2015 36 pages

Epiomic Epidemiology Series: Nocturia Forecast in 8 Major Markets 2015-2025

US$ 6,382.00

... level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Nocturia include: ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information form patient registries, clinical trials and epidemiology studies. All of the sources used ...

August 2015 38 pages

Epiomic Epidemiology Series: Gaucher's Disease Forecast in 9 Major Markets 2015-2025

US$ 6,382.00

Gaucher’s Disease (GD) is caused by an inherited, autosomal recessive ... data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient ... date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

August 2015 42 pages

Filters

Search

Categories

2
1
5
11
167

Publishers

186

Regions

2
1
1
182

Price

Date

Pages

Offers